trial · primary record
HRS-4642
Drug Interactions
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2026-11 |
| Primary endpoint | Maximum Observed Plasma Concentration (Cmax) of Total HRS-4642 Following Administration Alone |
| Registry ID | NCT07894679 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:47.927Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07894679
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.